In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has ...
SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...
Last year, the board voted to deem Enbrel “unaffordable,” setting up a months-long process of determining whether it should set a price ceiling.
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription drug costs. In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed ...
THOUSAND OAKS, Calif. and NEW YORK, May 25, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Pfizer Inc. (NYSE: PFE) today announced new results from multiple studies of ENBREL, further expanding the ...
A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions about whether a single state can reduce ...
THOUSAND OAKS, Calif., and RADNOR, Penn., – New data from multiple studies evaluating the use of ENBREL® (etanercept), the only fully human TNF receptor, in patients with long-standing disease, as ...
The safety of etanercept in this patient population was established through multiple pediatric trials, including a clinical study in 69 children aged 2 to 17 years with moderately to severely active ...
Sofusa is a drug delivery platform technology which delivers biologic therapies through the skin directly into the lymphatic system with potential to improve efficacy and safety and reduce the ...
A drugmaker whose product could be the first subjected to a price cap in Colorado is suing to throw out the state board that deemed its medication unaffordable. In February, the Colorado Prescription ...
Susan Estrich is the Robert Kingsley Professor of Law and Political Science at the University of Southern California Law Center as well as being a syndicated columnist. The U.S. government this week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results